FIELD: medicine.
SUBSTANCE: invention concerns pharmaceutical technology and medicine and concerns a compound for capsules. The compound includes the β form of 2,4 dioxo-6-methyl-1,2,3,4-tetrahydropyrimidin as active substance. It also contains talc, calcium stearate and sucrose at a certain parity of components.
EFFECT: peroral intake of an agent; absence of irritating action on mucous coat of stomach.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION FOR CAPSULES | 1996 |
|
RU2145846C1 |
| COMPOSITION FOR CAPSULES | 1996 |
|
RU2145847C1 |
| COMPOUND FOR CAPSULES | 1996 |
|
RU2363452C2 |
| DRUG PREPARATION IN FORM OF CAPSULES EXHIBITING ANTIVIRAL AND INTERFERONOGENIC ACTION | 2010 |
|
RU2446803C1 |
| NOVEL CRYSTALLINE MODIFICATION OF 5-FLUORO-1-(TETRAHYDRO-2-FURYL)-URACIL AND COMPLEX COMPOUNDS BASED ON THEREOF EXHIBITING ANTITUMOR EFFECT | 1998 |
|
RU2198171C2 |
| ANTIVIRAL DRUG AS CAPSULES AND METHOD FOR ITS PREPARATION | 2014 |
|
RU2633085C2 |
| COMPOSITION FOR IMPROVING CEREBRAL CIRCULATION | 2002 |
|
RU2222318C2 |
| 4,4'-SULFONYL-BIS-(N,N'-DIMETHYLAMMONIOMETHYLENEANILINE)-CHLORIDE, 6-METHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-SULFONATE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2004 |
|
RU2275356C2 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF THYROID DISEASES | 2017 |
|
RU2655307C1 |
| SOLID DOSAGE FORM OF PROCARBAZINE OF IMMEDIATE RELEASE AND PREPARATION METHOD THEREOF | 2014 |
|
RU2586290C1 |
